Hydrocortisone Aceponate + Miconazole Nitrate + Gentamicin Sulfate

Verify with FDA CVM →

27 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
27
Total Reports
3
Deaths Reported
1110.0%
Death Rate

Active Ingredients

Hydrocortisone Aceponate + Miconazole Nitrate + Gentamicin Sulfate

Administration Routes

UnknownAuricular (Otic)

Species Affected

Dog 27

Most Affected Breeds

Retriever - Labrador 5
Retriever - Golden 3
Pinscher - Miniature 3
Dog (unknown) 2
Bichon Frise 1
Terrier - Jack Russell 1
Bulldog - French 1
Spaniel - Cocker American 1
Lhasa Apso 1
Beagle 1

Most Reported Reactions

Emesis 9
Diarrhoea 7
Lethargy (see also Central nervous system depression in Neurological) 6
Inappetence 5
Other abnormal test result NOS 5
Vomiting 5
Abnormal radiograph finding 4
Trembling 4
Ear infection NOS 4
Otitis externa 4
Lack of efficacy - NOS 3
Weight gain 3

Outcome Breakdown

Recovered/Normal
13 (48.1%)
Outcome Unknown
7 (25.9%)
Died
3 (11.1%)
Recovered with Sequela
2 (7.4%)
Ongoing
2 (7.4%)

Data Summary

Metric Value
Total adverse event reports 27
Reports involving death 3
Case-fatality rate (reported events) 1110.0%
Distinct species in reports 1
Distinct breeds in reports 18
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Hydrocortisone Aceponate + Miconazole Nitrate + Gentamicin Sulfate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 27 adverse event reports referencing Hydrocortisone Aceponate + Miconazole Nitrate + Gentamicin Sulfate, including 3 reports in which the animal died — a 1110.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Hydrocortisone Aceponate + Miconazole Nitrate + Gentamicin Sulfate. Reported administration routes include Unknown, Auricular (Otic). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Hydrocortisone Aceponate + Miconazole Nitrate + Gentamicin Sulfate reports are Dog (27 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (5), Retriever - Golden (3), Pinscher - Miniature (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Hydrocortisone Aceponate + Miconazole Nitrate + Gentamicin Sulfate are Emesis (9), Diarrhoea (7), Lethargy (see also Central nervous system depression in Neurological) (6), Inappetence (5). Of the 27 reports with a coded outcome, Recovered/Normal is the leading category at 48.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Hydrocortisone Aceponate + Miconazole Nitrate + Gentamicin Sulfate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial